Immunotherapy for Pancreatic Cancer

In this summary, Robert H. Vonderheide, MD, DPhil, offers an overview of recent advances at Penn Medicine in immunological therapy for pancreatic cancer based upon antibodies that activate the patient's immune system to attack the ""scaffolding"" that supports pancreatic malignancies. 

Related Links

• View Clinical Briefing: EMT and Dissemination Precede Pancreatic Tumor Formation
• View Clinical Research Information: Pancreatic Cancer Research
• View Dr Stanger's Profile